NCT02960594: hTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of Relapse |
|
|
| Completed | 1 | 93 | US | INO-1400, hTERT, INO-9012, IL-12, INO-1401, SynCon TERT | Inovio Pharmaceuticals, University of Pennsylvania, University of North Carolina, Thomas Jefferson University, University of Pittsburgh, Barbara Ann Karmanos Cancer Institute, Mayo Clinic | Breast Cancer, Lung Cancer, Pancreatic Cancer, Head and Neck Cancer, Ovarian Cancer, ColoRectal Cancer, Gastric Cancer, Esophageal Cancer, HepatoCellular Carcinoma | 11/18 | 11/18 | | |
